Related Experiment Videos
[Frequent airway infections]
H Hohage1, B Otte, A Raffelsiefer
1Medizinische Poliklinik, Westfälische Wilhelms-Universität, M[nster.
Praxis
|November 14, 1995
Summary
A 44-year-old patient with variable immunodeficiency syndrome experienced allergic reactions to immunoglobulin therapy. Pretreatment with antihistamines managed reactions, leading to reduced infections.
Area of Science:
- Immunology
- Pulmonology
Background:
- Variable immunodeficiency syndrome (Common variable immunodeficiency - CVID) is a primary immunodeficiency characterized by low immunoglobulin levels and impaired antibody production.
- Patients with CVID are susceptible to recurrent sinopulmonary infections, which can lead to chronic lung disease.
Observation:
- A 44-year-old patient presented with worsening dyspnea and productive cough, exhibiting cicatricial changes in the right lung on chest X-ray.
- Laboratory tests revealed significantly reduced plasma gamma-globulin levels, indicating a global deficiency in all immunoglobulins.
Findings:
- The patient was diagnosed with variable immunodeficiency syndrome after excluding other acquired causes.
- Antibiotic treatment with gyrase-inhibitors was initiated, followed by an immunoglobulin-substitution program.
- An allergic reaction occurred during immunoglobulin infusion, which was successfully managed with antihistamine pretreatment.
Implications:
- Immunoglobulin replacement therapy is crucial for managing CVID, significantly reducing infection incidence and severity.
- Careful monitoring and management of potential adverse reactions, such as allergic responses, are essential for successful immunoglobulin therapy.
- This case highlights the importance of timely diagnosis and appropriate management of CVID to prevent long-term complications and improve patient outcomes.